Harry Mansbach

Harry Mansbach

Chief Tech/Sci/R&D Officer at 89BIO, INC.

Net worth: 2 M $ as of 30/03/2024

59 year
Health Technology
Consumer Services
Health Services

Profile

Harry H.
Mansbach
is currently the Chief Medical Officer at 89bio, Inc. He previously worked as the Director of Clinical Development & Neurosciences at GlaxoSmithKline LLC, Senior VP & Head of Global Drug Development at Bausch Health Americas, Inc., Chief Medical Officer & VP of Clinical Development at RespireRx Pharmaceuticals, Inc., Head of Global Clinical Development at Ultragenyx Pharmaceutical, Inc., and Vice President of Medical Affairs at Medivation LLC.
He was also a member of the Neurology Department at Henry Ford Health System.
Mansbach holds a doctorate from Duke University and an undergraduate degree from Yale University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
16/02/2024 158,437 ( 0.17% ) 2 M $ 30/03/2024

Harry Mansbach active positions

CompaniesPositionStart
89BIO, INC. Chief Tech/Sci/R&D Officer 30/11/2018
All active positions of Harry Mansbach

Former positions of Harry Mansbach

CompaniesPositionEnd
ULTRAGENYX PHARMACEUTICAL INC. Chief Tech/Sci/R&D Officer 30/11/2018
MEDIVATION INC Chief Tech/Sci/R&D Officer 31/03/2015
RESPIRERX PHARMACEUTICALS INC. Chief Tech/Sci/R&D Officer 14/12/2006
Chief Tech/Sci/R&D Officer -
Corporate Officer/Principal -
See the detail of Harry Mansbach's experience

Training of Harry Mansbach

Duke University Doctorate Degree
Yale University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Harry Mansbach's experience

Connections

64

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
RESPIRERX PHARMACEUTICALS INC.

Health Technology

ULTRAGENYX PHARMACEUTICAL INC.

Health Technology

Private companies5

Health Technology

Health Services

Health Technology

Health Technology

89bio, Inc.

See company connections
  1. Stock Market
  2. Insiders
  3. Harry Mansbach